Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Longitudinal evaluation the pulmonary function of the pre and postoperative periods in the coronary artery bypass graft surgery of patients treated with a physiotherapy protocol

  • Adalgiza M Moreno1,
  • Renata RT Castro1,
  • Pedro PS Sorares2,
  • Mauricio Sant' Anna3,
  • Sergio LD Cravo4 and
  • Antônio CL Nóbrega1, 2Email author
Journal of Cardiothoracic Surgery20116:62

https://doi.org/10.1186/1749-8090-6-62

Received: 3 February 2011

Accepted: 27 April 2011

Published: 27 April 2011

Abstract

Background

The treatment of coronary artery disease (CAD) seeks to reduce or prevent its complications and decrease morbidity and mortality. For certain subgroups of patients, coronary artery bypass graft surgery (CABG) may accomplish these goals. The objective of this study was to assess the pulmonary function in the CABG postoperative period of patients treated with a physiotherapy protocol.

Methods

Forty-two volunteers with an average age of 63 ± 2 years were included and separated into three groups: healthy volunteers (n = 09), patients with CAD (n = 9) and patients who underwent CABG (n = 20). Patients from the CABG group received preoperative and postoperative evaluations on days 3, 6, 15 and 30. Patients from the CAD group had evaluations on days 1 and 30 of the study, and the healthy volunteers were evaluated on day 1. Pulmonary function was evaluated by measuring forced vital capacity (FVC), maximum expiratory pressure (MEP) and Maximum inspiratory pressure (MIP).

Results

After CABG, there was a significant decrease in pulmonary function (p < 0.05), which was the worst on postoperative day 3 and returned to the preoperative baseline on postoperative day 30.

Conclusion

Pulmonary function decreased after CABG. Pulmonary function was the worst on postoperative day 3 and began to improve on postoperative day 15. Pulmonary function returned to the preoperative baseline on postoperative day 30.

Background

The treatment of coronary artery disease (CAD) seeks to reduce or prevent its complications and decrease morbidity and mortality. For certain subgroups of patients, coronary artery bypass graft surgery (CABG) may accomplish these goals [1].

Pulmonary dysfunction and associated complications are the major cause of morbidity and mortality in the period following cardiac CABG surgery [2]. The impairment of pulmonary function has multiple causes, including the use of a sternotomy, pleurotomy due to insertion of the left internal thoracic artery [2], pleural drain insertion [3], diaphragmatic dysfunction due to manipulation of the viscera and reflex dysfunction of the phrenic nerve caused by the use of cold cardioplegic solution [4, 5].

Van Belle et al. analyzed the pulmonary function of 18 patients before surgery and in the first and sixth weeks after CABG and concluded that respiratory muscle weakness contributed to the decrease in function seen in the first postoperative week. In another study with 37 patients who had undergone CABG, forced vital capacity (FVC) decreased by 70% in the immediate postoperative period and remained reduced in 35% of patients up to 3 weeks after surgery [6].

Many studies have shown the efficacy of physiotherapy, such as incentive spirometry [7] and respiratory muscle training [8], in minimizing pulmonary dysfunction during the preoperative and postoperative periods. However, these studies do not describe the effects on pulmonary dysfunction, especially volume reduction and respiratory muscle strength, over a sufficient period of time. Therefore, the present study aims to evaluate the effect of physiotherapy during cardiac rehabilitation phase I on pulmonary function in patients who underwent CABG.

Patients and methods

This longitudinal study included 42 subjects aged 48 to 78 years. Subjects were divided into the following three groups: patients who underwent CABG, patients with coronary artery disease (CAD) and healthy volunteers (HV). The CABG and CAD groups were recruited at the Hospital de Cardiologia Procordis.

Inclusion criteria

We Included for the study were, all candidates for elective coronary artery bypass graft surgery, were recruited and evaluated from January to 1999 to January to 2000, age 40 to 80 years and written informed consent and the study was approved by the institutional ethics committee (Resolution 196/96 of the National Health Council). The three groups were paired by age and gender. The patients included in the CAD and CABG groups were also paired in relation to the number of diseased blood vessels, verified by percutaneous coronary angiography (obstruction≥ 50%). All of the subjects from the CAD group had been previously recommended for CABG but instead chose medical treatment.

Exclusion criteria

We excluded patients who had a history of previous cardiac surgery, diabetes mellitus, pacemaker implantation, atrial fibrillation, chronic heart failure, utilization of intra-aortic balloon pump, mechanical ventilation longer than 24 hours, acute myocardial infarction within 6 months prior to the surgery, autonomic neuropathy and pulmonary disease.

Protocol

All the subjects in the CABG group had a preoperative evaluation and orientation in accordance to the physiotherapy procedures. After surgery, they had physiotherapy sessions twice a day for 30 minutes up to postoperative day 6 or until discharge from the hospital (Table 1).
Table 1

Physiotherapy protocol after extubation up to postoperative day 6 or hospital discharge

PO day

Physiotherapy protocol

1

CPAP with face mask for 20 minutes, reexpansion respiratory exercises, pursed lips breathing, incentive spirometry, huffing, coughing and transfer patient to an armchair

2

Same as PO day 1 walking around the patient's room

3 and 4

Respiratory reexpansion exercises, pursed lips breathing, incentive spirometry, a 60-meter walk and a walk down 17 stairs with the return upstairs using a lift (PO day 4)

5 and 6

Same as PO day 4, walk 120 meters and walk up a flight of stairs.

PO = postoperative; CPAP = continuous positive airway pressure.

After discharge, all groups received physiotherapy, which included respiratory exercises and walking. They were monitored for 30 days and were evaluated on the following schedules: day 1 for the HV control group, days 1 and 30 for the CAD group, and preoperation and postoperative days 3, 6, 15 and 30 for the CABG group.

Ventilation test

The pulmonary function tests were performed to measure FVC were measured by spirometry (Spirodoc- Mir; Rome, Italy). For the procedures, subjects sat with their feet resting on the floor. They were asked to inhale deeply to measure the total lung capacity (TLC) and to strongly exhale into the spirometer's mouthpiece to measure the residual volume (RV). Three tests were performed, and the best result was selected. The reference values in the Guidelines for the Pulmonary Function Testing were used for this study [9].

Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) were measured with manuvacuometers (M120 healthcare; 2001; São Paulo, Brazil) to verify static respiratory pressure. The manuvacuometer mouthpiece has 2-mm holes that dissipate the pressures generated by the facial muscles and the oropharynx. To measure the MIP, individuals were instructed to exhale up to the RV, inhale deeply with the manuvacuometer's mouthpiece (Müller's maneuver) in place and maintain the strain with their respiratory muscles for 3 seconds [10].

To measure the MEP, participants were instructed to deeply inhale up to the TLC, do a forced exhalation (Valsalva maneuver) and maintain the strain with their respiratory muscles for 3 seconds.

Physiotherapy of protocol

On the day preceding surgery, patients received orientation and training regarding the physiotherapeutic procedures to be conducted in the postoperative period, such as re-expansion respiratory exercises, pursed lips breathing, flow and volume incentive spirometry, huffing, holding a cough pillow to the chest and continuous positive airway pressure (CPAP) by face mask. In the first 12 hours after surgery, the subjects were extubated, they received CPAP for 20 minutes and they continued respiratory exercises, such as huffing and directed coughing, from postoperative days 1 to 6 (Table 1).

Statistical analyses

Statistical analysis was performed in Statistica version 7.0 (Stasoft Corporation, Tulsa, USA). Sample size was calculated and resulted in 10 patients, to achieve an alpha error of 0.05 and power of 0.9. Two-way ANOVA was used for repeated measures. The main factors were time and groups (control, CABG and CAD). When differences were found, the Bonferroni post-hoc analysis was used, and p < 0.05 was considered statistically significant. To compare anthropometric variables in the three groups, single-factor ANOVA (group) was used. Chi-square analysis was used to compare rates of medication use.

Results

FVC, MIP and MEP were all normal in the HV control group (n = 13). The CAD group contained nine subjects. For the CABG group, 20 patients were recruited and 7 were excluded for the following reasons: diagnosis of lung cancer, pneumonia, study withdrawal and death. The 13 remaining patients (5 females and 8 males) had an average age of 63 ± 2 years (Tables 2). The anesthetic drugs used in the CABG group during surgery were pancuronium, propofol, fentanyl, midazolam and diazepam.
Table 2

Anthropometric, clinical and surgical characteristics of each group of subjects

Characteristics

CABG (n = 13)

CAD (n = 9)

Control (n = 9)

Gender (male/female)

8/5

5/4

5/8

Age (years)

64 ± 2

64 ± 2

63 ± 2

BMI (kg/m2)

27.6 ± 0.6

27.4 ± 0.7

26.5 ± 0.9

Number of veins

3 ± 1

3 ± 1

 

Torrington and Henderson scale (points)

4

4

 

Extracorporeal circulation time (min)

85 ± 24

  

AC (min)

56 ± 18

  

TTOT (hours) Medications

4.2 ± 2.3

  

   ACE inhibitors

5

6

 

   Digitalis

3

0

 

   Antiarrhythmic drugs

1

0

 

   ASA

7

3

 

   Calcium channel antagonists

4

1

 

CABG = coronary artery bypass graft; CAD = coronary artery disease; BMI = body mass index; AC = aortic clamping; ACE = angiotensin-converting enzyme; TTOT = orotracheal intubation time; ASA = acetylsalicylic acid

At the first evaluation, there were no significant differences in FVC, MIP or MEP among the groups (p > 0.05) (Figure 1). In the CABG group, there was a statistically significant decrease in the FVC (p < 0.05) on postoperative days 3 and 5. The biggest decrease was on postoperative day 3, and lung function returned to the preoperative level by postoperative day 15 (Figure 1).
Figure 1

Forced vital capacity, maximal inspiratory pressure and maximal expiratory pressure in the preoperative period and on postoperative days 3, 6, 15 and 30. *p < 0.05 pre vs. days in CABG. FVC = forced vital capacity; MEP = maximal expiratory pressure; MIP = maximal inspiratory pressure; CABG = coronary artery bypass graft; CAD = coronary artery disease; HV = healthy volunteers

The MIP significantly decreased (p < 0.05) in the CABG group on postoperative days 3, 6 and 15 compared to the preoperative MIP. The MIP returned to the preoperative value by postoperative day 30 (Figure 1). The MEP was significantly decreased (p < 0.05) on postoperative days 3 and 6 and returned to the preoperative baseline by postoperative day 15.

Discussion

Many factors have been suggested to be responsible for the decrease in pulmonary function and consequently FVC [1] and muscular strength after CABG. Some suggested factors include anesthesia, analgesics, surgical stress, pain [11], reduced ventricular function, phrenic nerve injury, cardiovascular drugs, extracorporeal circulation (EC) [12] and the position of the drains [13].

Pain due to thoracotomy is a limiting factor for mobility and breathing. A high level of postoperative pain is common because of the cutting of the skin, muscles and pleura as well as the retraction of muscles and ligaments, pleural and septal nerve irritation from thoracic drains and occasional rib fractures [14].

Yung et al.[15] studied the analgesic effect of morphine infusion via spinal catheter in 40 revascularized patients. They found a significant reduction in pain, respiratory insufficiency, extubation time and reintubation percentage compared to the control group. Although analgesia is necessary for shortening mechanical ventilation time and must be given during the first few postoperative hours, analgesia in the postoperative period interferes with pulmonary function. In this study, the analgesic dosing was standardized (Table 2).

Pain may also contribute to decreased cough efficiency, which is the main mechanism for the elimination of secretions from the tracheobronchial tree due to the immobility of the thoracic wall. This immobility causes superficial breathing, which may result in atelectasis, inadequate ventilation-perfusion ratio and pneumonia. These complications lead to increased morbidity [13].

Our results showed a 33% decrease in pulmonary function on postoperative day 3 and a 23% decrease on postoperative day 6 compared to the preoperative period. These results are similar to the existing literature on pulmonary function on postoperative day 6 ([1620]).

In a study developed by Shernkman et al. with 37 subjects who underwent CABG, there was a 70% decrease in FVC immediately after surgery. FVC remained reduced in 35% of subjects up to 3 weeks after surgery. We can attribute this difference to the physiotherapy that our subjects received up to postoperative day 6 [16].

Left ventricular dysfunction, which increases extravascular fluid in the lungs, leading to altered lung compliance and increased pulmonary resistance, may result in increased respiratory work and oxygen consumption [21, 22].

Phrenic nerve injury may also cause a reduction in pulmonary function. Anatomically, the right phrenic nerve travels between the pericardium and the mediastinal pleura, and the left phrenic nerve descends between the subclavian artery and left common carotid lateral to the vagus nerve and anterior to the left lung root. Proposed mechanisms for phrenic nerve injury include decreased nerve conductance due to the freezing of the myocardium in the preoperative period for myocardial preservation [17, 22], reduced perfusion of the phrenic nerve due to injury of the branches of the internal mammary artery during dissection [21, 23], trauma to the phrenic nerve during sternotomy [24] and internal jugular vein puncture [18, 22].

Phrenic nerve injury during heart surgery has an incidence of 26% [23] and may cause diaphragmatic paresis. The right phrenic nerve is more commonly injured, and, rarely, bilateral injury can occur [7].

Pulmonary function after CABG and physiotherapy All patients undergoing CABG received physiotherapy from before the operation up to postoperative day 6. Haeffener et al.[25] demonstrated the efficacy of positive expiratory pressure (PEP) respiratory incentive spirometry in preventing pulmonary complications after heart surgery. Their sampling was composed of 34 patients who underwent CABG (PEP group, n = 17; control group, n = 17). Their results were similar to the results of this study in relation to the decrease in pulmonary function in the PEP group. On postoperative day 7 there was a significant decrease in FVC, MIP, MEP and 6-minute walking test results, except for subjects in the PEP group. Notably, the PEP group had a lower rate of postoperative complications, such as pneumonia.

Borghi-Silva et al.[18] investigated the effects of respiratory physiotherapy with PEP incentive spirometry on phase I cardiovascular rehabilitation, pulmonary function and respiratory muscle strength after CABG. It was concluded that cardiac surgery reduces pulmonary function and the respiratory muscle strength, especially on postoperative day 5. However, the combination of physiotherapy and PEP incentive spirometry reduced these complications. Although PEP incentive spirometry is widely utilized in hospitals before and after CABG, its acute effects on cardiovascular function are not yet clear as the only data in this area are from healthy individuals [26].

Herdy et al.[7] investigated the hypothesis that respiratory physiotherapy might minimize adverse cardiopulmonary effects after CABG in 56 subjects (pulmonary rehabilitation group, n = 29; control group, n = 27). Pulmonary rehabilitation was started at least 5 days prior to the surgery, and the protocol adopted, similar to the one used by our group, included CPAP.

Subjects in the pulmonary rehabilitation group had less mechanical ventilation time, atelectasis, pneumonia and atrial fibrillation as well as a shorter hospitalization time.

Various studies have confirmed that this therapeutic modality contributes to decreased PaCO2, transpulmonary pressure, respiratory work and hypoxemia and increases pulmonary volumes, mainly FVC, to prevent atelectasis [26, 27]. For this reason we used CPAP in our experimental protocol.

Recently, many studies have investigated the benefits of respiratory muscle training [8, 27] for postoperative outcomes.

Hulzebos et al.[8] developed a randomized, experimental protocol to analyze the inspiratory muscle training (IMT) efficiency for minimizing pulmonary complications after CABG. Their study randomized 279 subjects to IMT (n = 140) or conventional treatment (n = 139). Both groups received the same treatment after surgery.

The protocol was started 10 weeks prior to surgery with IMT being performed 7 times a week for 20 minutes each time. Six sessions were unsupervised, and one was supervised. The protocol was initiated with 30% of the MIP. The IMT group had fewer postoperative pulmonary complications. It was concluded that IMT during the preoperative period minimized pulmonary complications after CABG.

Clinical implications

In this study, the alterations in pulmonary function and respiratory muscle strength in subjects after undergoing CABG demonstrate the need for early intervention in the preoperative period with the goal of optimizing pulmonary function. Physiotherapy, including incentive spirometry, should be continued in the postoperative period.

Limitations of the study

The present study should be interpreted in the light of some limitations. First of all, the sample size was small. Second, the intervention was carried out only during the hospitalization period, and the same physiotherapy protocol was utilized for all patients. It must be emphasized that for ethical reasons, it was not possible to have a control group that did not receive treatment. Therefore, this study is not intended to evaluate the effects of physiotherapy on the decrease in pulmonary function after CABG. However, we can infer that the treatment had a positive effect because we observed a lower degree of pulmonary dysfunction compared to that described in the literature.

Third, the time interval among the evaluations was relatively long, especially from postoperative days 6 to 15 and 15 to 30. As a result, we were not able to accurately define when pulmonary function returned to normal values.

Conclusion

Pulmonary function decreased after CABG. Pulmonary function was the worst on postoperative day 3 and began to improve on postoperative day 15. Pulmonary function returned to the preoperative baseline on postoperative day 30.

Declarations

Acknowledgements

We thank the Procordis Cardiology Hospital.

Authors’ Affiliations

(1)
Post-graduate Program in Cardiovascular Sciences, Fluminense Federal University
(2)
Department of Physiology and Pharmacology, Fluminense Federal University
(3)
Federal University of Rio de Janeiro
(4)
Department of Physiology, Universidade Federal de São Paulo

References

  1. von Ungern-Sternberg BS, Petak F, Saudan S, Pellegrini M, Erb TO, Habre W: Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J Thorac Cardiovasc Surg. 2007, 134 (5): 1193-8. 10.1016/j.jtcvs.2007.03.061.View ArticlePubMedGoogle Scholar
  2. Wynne R, Botti M: Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice. Am J Crit Care. 2004, 13 (5): 384-93.PubMedGoogle Scholar
  3. Vargas FS, Terra-Filho M, Hueb W, Teixeira LR, Cukier A, Light RW: Pulmonary function after coronary artery bypass surgery. Respir Med. 1997, 91 (10): 629-33. 10.1016/S0954-6111(97)90010-X.View ArticlePubMedGoogle Scholar
  4. Wiwanitkit V: Post-cardiac surgery anesthesia: comparison of patient-controlled regimens. Rev Bras Cir Cardiovasc. 25 (3): 429-Google Scholar
  5. Tzani P, Chetta A, Olivieri D: Patient assessment and prevention of pulmonary side-effects in surgery. Curr Opin Anaesthesiol.Google Scholar
  6. van Belle AF, Wesseling GJ, Penn OC, Wouters EF: Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Respir Med. 1992, 86 (3): 195-9. 10.1016/S0954-6111(06)80054-5.View ArticlePubMedGoogle Scholar
  7. Herdy AH, Marcchi PL, Vila A, Tavares C, Collaco J, Niebauer J: Pre- and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery: a randomized controlled trial. Am J Phys Med Rehabil. 2008, 87 (9): 714-9. 10.1097/PHM.0b013e3181839152.View ArticlePubMedGoogle Scholar
  8. Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL: Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. Jama. 2006, 296 (15): 1851-7. 10.1001/jama.296.15.1851.View ArticlePubMedGoogle Scholar
  9. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995, 152 (3): 1107-36.Google Scholar
  10. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002, 166 (4): 518-624.Google Scholar
  11. Zahler S, Massoudy P, Hartl H, Hahnel C, Meisner H, Becker BF: Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res. 1999, 41 (3): 722-30. 10.1016/S0008-6363(98)00229-6.View ArticlePubMedGoogle Scholar
  12. Gow KW, Lao OB, Leong T, Fortenberry JD: Extracorporeal life support for adults with malignancy and respiratory or cardiac failure: The Extracorporeal Life Support experience. Am J Surg May. 199 (5): 669-75.Google Scholar
  13. Jakobsen CJ, Torp P, Sloth E: Perioperative feasibility of imaging the heart and pleura in patients with aortic stenosis undergoing aortic valve replacement. Eur J Anaesthesiol. 2007, 24 (7): 589-95. 10.1017/S0265021506002328.View ArticlePubMedGoogle Scholar
  14. Lichtenberg A, Hagl C, Harringer W, Klima U, Haverich A: Effects of minimal invasive coronary artery bypass on pulmonary function and postoperative pain. Ann Thorac Surg. 2000, 70 (2): 461-5. 10.1016/S0003-4975(00)01505-8.View ArticlePubMedGoogle Scholar
  15. Yung MC, Chang Y, Lai ST, Tsou MY, Chan KH: Improved postoperative pain relief via preemptive analgesia in relation to heart rate variability for coronary artery bypass grafting: a preliminary report. Zhonghua Yi Xue Za Zhi (Taipei). 1997, 60 (1): 28-35.Google Scholar
  16. Shenkman Z, Shir Y, Weiss YG, Bleiberg B, Gross D: The effects of cardiac surgery on early and late pulmonary functions. Acta Anaesthesiol Scand. 1997, 41 (9): 1193-9. 10.1111/j.1399-6576.1997.tb04865.x.View ArticlePubMedGoogle Scholar
  17. Rousou JA, Parker T, Engelman RM, Breyer RH: Phrenic nerve paresis associated with the use of iced slush and the cooling jacket for topical hypothermia. J Thorac Cardiovasc Surg. 1985, 89 (6): 921-5.PubMedGoogle Scholar
  18. Borghi-Silva A, Mendes RG, Costa Fde S, Di Lorenzo VA, Oliveira CR, Luzzi S: The influences of positive end expiratory pressure (PEEP) associated with physiotherapy intervention in phase I cardiac rehabilitation. Clinics (Sao Paulo). 2005, 60 (6): 465-72.View ArticleGoogle Scholar
  19. Bonacchi M, Prifti E, Giunti G, Salica A, Frati G, Sani G: Respiratory dysfunction after coronary artery bypass grafting employing bilateral internal mammary arteries: the influence of intact pleura. Eur J Cardiothorac Surg. 2001, 19 (6): 827-33. 10.1016/S1010-7940(01)00695-9.View ArticlePubMedGoogle Scholar
  20. Ragnarsdottir M, KristjAnsdottir A, Ingvarsdottir I, Hannesson P, Torfason B, Cahalin L: Short-term changes in pulmonary function and respiratory movements after cardiac surgery via median sternotomy. Scand Cardiovasc J. 2004, 38 (1): 46-52. 10.1080/14017430310016658.View ArticlePubMedGoogle Scholar
  21. O'Brien JW, Johnson SH, VanSteyn SJ, Craig DM, Sharpe RE, Mauney MC: Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann Thorac Surg. 1991, 52 (2): 182-8. 10.1016/0003-4975(91)91334-R.View ArticlePubMedGoogle Scholar
  22. Armengaud MH, Trevoux-Paul J, Boucherie JC, Cousin MT: [Diaphragmatic paralysis after puncture of the internal jugular vein]. Ann Fr Anesth Reanim. 1991, 10 (1): 77-80.View ArticlePubMedGoogle Scholar
  23. DeVita MA, Robinson LR, Rehder J, Hattler B, Cohen C: Incidence and natural history of phrenic neuropathy occurring during open heart surgery. Chest. 1993, 103 (3): 850-6. 10.1378/chest.103.3.850.View ArticlePubMedGoogle Scholar
  24. Markand ON, Moorthy SS, Mahomed Y, King RD, Brown JW: Postoperative phrenic nerve palsy in patients with open-heart surgery. Ann Thorac Surg. 1985, 39 (1): 68-73. 10.1016/S0003-4975(10)62524-6.View ArticlePubMedGoogle Scholar
  25. Haeffener MP, Ferreira GM, Barreto SS, Arena R, Dall'Ago P: Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J. 2008, 156 (5): 900 e1-e8.View ArticlePubMedGoogle Scholar
  26. Bersten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ: Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med. 1991, 325 (26): 1825-30. 10.1056/NEJM199112263252601.View ArticlePubMedGoogle Scholar
  27. Taylor BJ, Romer LM: Effect of expiratory resistive loading on inspiratory and expiratory muscle fatigue. Respir Physiol Neurobiol. 2009, 166 (3): 164-74. 10.1016/j.resp.2009.03.002.View ArticlePubMedGoogle Scholar

Copyright

© Moreno et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.